Exco InTouch Shortlisted for the Best Technological Development in Clinical Trials 2014 SCRIP Award
News Oct 04, 2014
Exco InTouch has announced that its mDNA® technology project team have been shortlisted for the “Best Technological Development in Clinical Trials” category for the 2014 SCRIP Awards.
The innovative technology is a diagnostic and data handling tool providing secure and anonymous data communication and storage for clinical trials. Through interrogating the device in use, mDNA® facilitates a BYOD (Bring Your Own Device) approach in clinical research, as well as enabling content to be displayed appropriately, enhancing the familiarity and usability for each trial participant. Moreover, mDNA® supports essential data security and privacy controls by segregating Personally Identifiable Information (PII) in accordance EU Data Protection, Safe Harbor, and HIPAA data protection regulations.
As a leading electronic Clinical Outcomes Assessment (eCOA) and electronic Patient Reported Outcomes (ePRO) provider, Exco InTouch is committed to developing novel technology, like mDNA®, and to driving innovation to improve clinical trials to the benefit of both clinicians and patients. Exemplifying the company’s commitment to technological development, Exco InTouch recently unveiled further innovation by announcing that it is the only eCOA provider to have published native apps on all major mobile operating platforms, including iOS, Android and Windows8.
Tim Davis, CEO and founder of Exco InTouch commented: “We are delighted to have been shortlisted for this award. Indeed, we have an established track record for driving technological innovation in the field of digital data capture and patient engagement solutions in order to optimize efficiencies in clinical trials to the benefit of both clinicians and patients. Our proprietary mDNA® technology is a prime example of this and we are pleased that it has received such industry recognition. We look forward to continuing to take a lead in this critically important area”.
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Microbiotica Enters into Microbiome Collaboration with GenentechNews
Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.READ MORE
Chemoradiotherapy Before Surgery Could Extend Lives of Pancreatic Cancer PatientsNews
Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery, according to unpublished clinical trial results.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018